These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9511045)

  • 21. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
    Kern WV; Klose K; Jellen-Ritter AS; Oethinger M; Bohnert J; Kern P; Reuter S; von Baum H; Marre R
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):111-8. PubMed ID: 15714332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
    Takahashi H; Kikuchi T; Shoji S; Fujimura S; Lutfor AB; Tokue Y; Nukiwa T; Watanabe A
    J Antimicrob Chemother; 1998 Jan; 41(1):49-57. PubMed ID: 9511037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship of fluoroquinolone in Escherichia coli.
    Lee S; Park T; Lee Y
    Arch Pharm Res; 1998 Apr; 21(2):106-12. PubMed ID: 9875416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
    Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
    J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel alanine to serine substitution mutation in SoxS induces overexpression of efflux pumps and contributes to multidrug resistance in clinical Escherichia coli isolates.
    Aly SA; Boothe DM; Suh SJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2228-33. PubMed ID: 25921515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of fluoroquinolone resistance: an update 1994-1998.
    Piddock LJ
    Drugs; 1999; 58 Suppl 2():11-8. PubMed ID: 10553699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J; Hooper DC
    Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.
    Morgan-Linnell SK; Becnel Boyd L; Steffen D; Zechiedrich L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):235-41. PubMed ID: 18838592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of organic solvent tolerance by disruption of the lon gene in Escherichia coli.
    Watanabe R; Doukyu N
    J Biosci Bioeng; 2014 Aug; 118(2):139-44. PubMed ID: 24571965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of marA, soxS and acrB in veterinary isolates of Salmonella enterica rarely correlates with cyclohexane tolerance.
    Webber M; Buckley AM; Randall LP; Woodward MJ; Piddock LJ
    J Antimicrob Chemother; 2006 Apr; 57(4):673-9. PubMed ID: 16492722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple Antimicrobial Resistance and Novel Point Mutation in Fluoroquinolone-Resistant Escherichia coli Isolates from Mangalore, India.
    Santhosh KS; Deekshit VK; Venugopal MN; Karunasagar I; Karunasagar I
    Microb Drug Resist; 2017 Dec; 23(8):994-1001. PubMed ID: 28445079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
    Weigel LM; Anderson GJ; Facklam RR; Tenover FC
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones.
    Goldman JD; White DG; Levy SB
    Antimicrob Agents Chemother; 1996 May; 40(5):1266-9. PubMed ID: 8723480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone-resistant Escherichia coli, Indonesia.
    Kuntaman K; Lestari ES; Severin JA; Kershof IM; Mertaniasih NM; Purwanta M; Hadi U; Johnson JR; van Belkum A; Verbrugh HA;
    Emerg Infect Dis; 2005 Sep; 11(9):1363-9. PubMed ID: 16229763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS; Fisher LM
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Organic solvent tolerance in Escherichia coli].
    Aono R; Nakajima H
    Tanpakushitsu Kakusan Koso; 1997 Nov; 42(15):2532-41. PubMed ID: 9391342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.